D
eposition of the amyloid-␤ peptide (A␤) in senile plaques is a pathological hallmark of Alzheimer's disease (1) . A␤ is derived by proteolytic processing from the ␤-amyloid precursor protein (APP) through the combined action of ␤-secretase and ␥-secretase. Whereas ␤-secretase has recently been identified as the membrane bound aspartyl protease BACE (␤ site APP cleaving enzyme; ref. 2) , the identity of ␥-secretase has remained elusive. Recent evidence suggests that ␥-secretase is a large protein complex with an aspartyl protease activity that may consist of either of the two presenilin (PS) proteins PS1 and PS2 as catalytic subunit (3) and other probably regulatory proteins such as Nicastrin (4, 5) . Consistent with a role as catalytic subunit of ␥-secretase, PSs contain two highly conserved aspartates in the putative transmembrane domains (TM) 6 and 7. Mutagenesis of these aspartates in PS1 or PS2 reduces A␤ production (6) (7) (8) . Moreover, aspartyl protease transition-state analogue inhibitors that block ␥-secretase can be directly cross-linked to PSs (9, 10) . Finally, PSs share considerable sequence homology around the critical active site aspartate in TM7 with polytopic bacterial aspartyl proteases (11) .
PSs are also critically required for the site 3 (S3) intramembrane cleavage of Notch1 (12) and the related Notch2-4 proteins (13, 14) . S3 cleavage of Notch1 leads to the liberation of the Notch intracellular domain (NICD), a key molecule in cellular differentiation (15) that translocates to the nucleus where it acts as a transcriptional coactivator. A role in nuclear signaling has also recently been suggested for C-terminal fragment (CTF)-␥ (16), the C-terminal cleavage product of ␥-secretase (17) , now generally termed AICD (APP intracellular domain; ref. 18 ). AICD results from predominant cleavage after leucine 49 of the A␤ domain of APP, a position that is analogous to the S3 cleavage site of Notch (18 -21) . This additional S3-like ␥-secretase cleavage of APP is PS-dependent and can be blocked by ␥-secretase inhibitors, including those that have been shown to bind to PSs (18, 20, 21) .
Rare mutations have been identified within the APP gene that are associated with familial Alzheimer's disease (FAD) . Almost all of these mutations cause the increased generation of the highly amyloidogenic 42-aa-long variant of A␤ (A␤ 42 ) that aggregates faster than the shorter A␤ 40 and is predominantly deposited in senile plaques (1) . However, by far the highest numbers of mutations linked with FAD have been identified in the PS1 gene. In addition, rare mutations causing FAD have also been found in the homologous PS2 gene. Like most of the FAD-associated APP mutations, FAD mutations in PS1 and PS2 cause the increased generation of A␤ 42 . Interestingly, several FAD-associated PS1 mutations have been shown to impair Notch signaling (22) and consistent with this observation showed reduced rescuing activity of the egg-laying defect of a mutant Caenorhabditis elegans sel-12 PS homologue (23, 24) . However, the FAD-associated PS1 A246E mutant has been shown to rescue the phenotype of PS1 Ϫ/Ϫ mice (25, 26) , a discrepancy that is currently not understood.
Several of the FAD-linked mutations in the PS genes are found to cluster within the predicted ␣-helical TMs. Among other TMs, TM3 has been identified as a critical site where several FAD mutations of PS1 are located. Here we studied the effects of a previously uncharacterized FAD-associated mutation in TM3 (PS1 L166P) on APP and Notch endoproteolysis. Surprisingly, this mutation not only caused an exceptional increase of pathological A␤ 42 generation but also reduced proteolytic production of NICD and AICD, demonstrating that FADassociated PS mutants cannot only affect the generation of NICD, but also that of AICD. Interestingly, data resulting from This paper was submitted directly (Track II) to the PNAS office.
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additional mutagenesis demonstrate that pathogenic A␤ 42 production and proteolytic generation of AICD or NICD are differentially affected by PS1 L166 mutants. Finally, we show that PS1 L166 mutants affect NICD and AICD generation in a similar manner, suggesting that S3 protease cleavage and the S3-like ␥-secretase cleavage are mediated by the same PSdependent ␥-secretase activity. cDNA Constructs, Cell Culture, and Cell Lines. cDNA constructs encoding PS1 L166 mutants were generated as described (11) and cloned into the pcDNA3.1͞zeo(ϩ) expression vector (Invitrogen). Human embryonic kidney 293 (K293) cells were transfected and cultured as described (11) . K293͞sw cells stably expressing Swedish mutant APP (swAPP) have been described (29) .
Materials and Methods
Analysis of PSs, APP, and Notch Endoproteolysis. PSs (27) , APP, APP CTFs, secreted A␤ species (11) , and NICD generation (7, 30) were analyzed as described. AICD generation was analyzed in vitro from membrane preparations of stably transfected K293͞sw cells. Equal amounts of cells were resuspended (at least 0.5 ml per 10-cm dish) in homogenization buffer [10 mM Mops (pH 7.0)͞10 mM KCl] containing 1ϫ protease inhibitors (PI; Complete, Roche Molecular Biochemicals) and homogenized using a freeze-thaw procedure. Following swelling on ice for 10 min, cells were frozen in liquid N 2 for 5 min and allowed to thaw 28 min on ice and 2 min at RT. Equal volumes of the homogenate were centrifuged for 10 min at 1,000 ϫ g at 4°C to prepare a post nuclear supernatant (PNS) fraction. In parallel, aliquots of the homogenate were solubilized in STEN-lysis buffer [50 mM Tris (pH 7.6)͞150 mM NaCl͞2 mM EDTA͞1% Nonidet P-40] and, after a clarifying spin, subjected to protein determination. Membranes were pelleted from the PNS by centrifugation for 20 min at 16,000 ϫ g at 4°C and resuspended (at least 75 l per 10-cm dish) in assay buffer [150 mM sodium citrate (pH 6.4)͞1 mM EDTA] according to the protein content determined in the aliquots of the homogenates above. To allow for AICD generation, aliquots of the membranes were incubated at 37°C for 1 h and analyzed for AICD as described (18) . Aliquots of the membranes that were not used for AICD generation were analyzed for APP and APP CTF levels. To facilitate detection of recombinant AICD variants, cells were treated with 1.66 mM 1,10-phenanthroline for 90 min before the preparation of cell lysates.
fibroblast cells were cotransfected with equal amount of either wild-type (wt) or L166 mutant PS1 cDNA and CBF1-luciferase reporter construct (31) by using Lipofectamine 2000 (GIBCO). The EGFP construct was also added at 1͞25 molar ratio to each transfectant to normalize the transfection efficiency. Luciferase activity was measured from cell lysates 24 h post-transfection according to manufacturer's suggested method (Promega).
Confocal Microscopy. Immunofluorescence was carried out as described (32) by using Alexa Fluor 488 (1:1,000, Molecular Probes) for detection. To detect cell nuclei of fixed cells, monomeric cyanine nucleic acid stain TO-PRO-3 iodide (1:1,000, Molecular Probes) was used. Confocal images were obtained with a Leica TCS SP confocal laser scanning microscope (Leica, Deerfield, IL). Single optical sections from each cell were chosen and processed using PHOTOSHOP software (Adobe Systems, Mountain View, CA).
Results
The PS1 L166P FAD Mutation Associated with Disease Onset in Adolescence Causes Greatly Increased A␤42 Generation and Impairs Notch Signaling. Several FAD mutations have been identified in TM3 of PS1, suggesting that this TM is an important site for PS function. Here we report a previously uncharacterized FADassociated mutation in TM3 of PS1 that changes the leucine residue at codon 166 to proline. This mutation is associated with an onset of AD in adolescence. In the female proband, secondary generalized seizures began at age 15, major depression occurred at 19, memory was clearly impaired by 24, ataxia and spastic paraparesis were recorded by 27, and moderate stage dementia by 28. Dementia, ataxia, and spasticity progressed until death at age 35. Numerous A␤-immunopositive neuritic and cotton wool plaques were seen throughout the cerebral cortex and A␤-immunopositive amyloid cores were abundant in the cerebellar cortex (J.M. and B.G., unpublished results).
Leucine 166 appears to be a rather important residue for PS function because it is conserved in all PSs, the only exceptions being the C. elegans PS homologue hop-1 and the Arabidopsis thaliana and Oryza sativa PSs. In addition, a FAD mutation changing leucine 166 to arginine has been identified in a Spanish family (33) . To investigate this critical site of PS1 in more detail, we examined the effects of the L166 FAD mutations, as well as of several artificial mutations at this residue on APP and Notch endoproteolysis. We first investigated the pathological activity of the two FAD-associated PS1 L166 mutants on A␤ production by using a tissue culture system that has previously been proven to be very sensitive for the detection of abnormal A␤ 42 generation (ref. 34 and references therein). cDNAs encoding wt PS1, PS1 L166P, and PS1 L166R were stably transfected into K293͞sw cells (29) and analyzed for PS expression. As shown in Fig. 1A , expression of wt PS1 and the L166 mutants allowed the generation of robust amounts of PS1 CTFs, demonstrating that the L166 mutants did not affect endoproteolysis of PS1. Functional expression of the PS1 variants was confirmed by the replacement of endogenous PS2 (ref. 35 ; Fig. 1 A) . We next analyzed the pathological function of the L166P and L166R mutation on total A␤, A␤ 40 , and A␤ 42 production. Conditioned media from metabolically labeled cells stably expressing wt PS1 or the two PS1 L166 FAD mutants were collected and analyzed for levels of total A␤ (Fig. 1B) or A␤ 40 and A␤ 42 species (Fig. 1C) . Although the levels of total A␤ were similar (Fig. 1B) , quantitation of A␤ 40 and A␤ 42 species revealed that the PS1 L166P caused a striking 5-to 6-fold increase of the A␤ 42 ͞A␤ total ratio (Fig. 1C and Table  1 ). Although not as high as observed for the L166P mutation, the L166R mutation showed a 3-fold increase of the A␤ 42 ͞A␤ total ratio ( Fig. 1C and Table 1 ). Comparison of the PS1 L166P mutant with the PS1 M146L, L286V, ⌬exon9, and G384A FAD mutants underlined its exceptional A␤ 42 increase (Fig. 1D ). This increase was comparable to that found for the PS1 G384A mutant (refs. 11 and 36; Fig. 1D ) and considerably higher than that found for the large majority of the PS1 mutations (37) .
We next investigated whether the L166P and L166R mutants also affect Notch signaling and assessed the activation of the Notch-dependent downstream transcription factor CBF1 (Cpromoter binding factor 1), using luciferase as a reporter gene (31) . PS1 Ϫ/Ϫ fibroblast cells were transiently transfected with wt PS1 or the PS1 L166P or L166R FAD mutants along with the CBF1-luciferase construct and activation of luciferase was measured. Robust luciferase activity was detected in PS1 Ϫ/Ϫ cells transfected with wt PS1 (Fig. 1E) . In contrast, significantly reduced luciferase activity was observed with the L166P and L166R mutants. Thus, these data demonstrate that in addition to producing aberrant amounts of A␤ 42 , the L166P and L166R mutants are also partially defective in Notch signaling.
Artificial L166 Mutants Cause Increased A␤42 Levels. To examine the consequences of L166 mutations on ␥-secretase cleavage in more detail, we changed leucine 166 to glutamate, alanine, serine, cysteine, and tryptophan. The respective cDNAs were stably transfected into K293͞sw cells. All mutants were expressed at similar levels and replaced endogenous PSs (data not shown). We then analyzed whether the various artificial L166 mutants affect A␤ 42 production. Conditioned media were collected from metabolically labeled cells expressing wt PS1 or the artificial L166 mutants and analyzed for A␤ 40 and A␤ 42 production. Quantitation revealed that all mutations increased the A␤ 42 ͞ A␤ total ratio to various extents, demonstrating that codon 166 is very sensitive to amino acid changes ( Table 1) . Introduction of the negatively charged amino acid glutamate led to the strongest elevation (4-to 5-fold) of the A␤ 42 ͞A␤ total ratio among the artificial L166 mutants. A rather strong increase in the A␤ 42 ͞ A␤ total ratio was also observed for the serine and alanine substitutions. In contrast, the cysteine and tryptophan substitutions elevated the A␤ 42 ͞A␤ total ratio only slightly, similar to the majority of the known PS1 mutations (37) . Thus, all artificial L166 mutants described here induce pathological A␤ 42 production and may therefore probably lead to AD if they occur in humans.
Differential Effects of PS1 L166 Mutants on Notch Endoproteolysis.
The results shown above suggest that the L166 mutants cause structural alterations of TM3 that result in an altered ␥-secretase cleavage and lead to variable production of A␤ 42 . We therefore Levels of A␤40 and A␤42 were analyzed in conditioned media of metabolically labeled K293͞sw cells stably expressing wt PS1, PS1 FAD (L166P and L166R), or artificial PS1 L166 mutants as described in Fig. 1C . Means Ϯ SE represent three independent experiments. Ratios are expressed relative to those in cells expressing wt PS1 that was set 1.00. P values indicate the significance (two-tailed Student's t test) relative to wt PS1.
next asked whether the various L166 mutants would also affect endoproteolysis of Notch. The above described cell lines expressing either wt PS1, FAD-linked, or artificial L166 mutations were transfected with the Notch⌬E (N⌬E) cDNA (38) and NICD formation was monitored in pulse-chase experiments as described (7) . As a control, K293͞sw cells stably co-expressing N⌬E with the PS1 D385A mutant were used. NICD production was observed in all cell lines with the exception of cells expressing the PS1 D385A mutant that led to an almost complete inhibition of NICD generation, consistent with previous results (7, 11, 30) . Consistent with impaired CBF1-mediated Notch signaling (Fig. 1E) , the FAD-associated mutations L166P and L166R showed a significantly impaired conversion of N⌬E to NICD ( Fig. 2A) . Marked impairment of NICD generation was also observed for the artificial L166W mutation, whereas the other L166 mutants displayed moderate or very little impairment in NICD formation. Quantitation confirmed the differential effects of the various L166 mutants on the conversion of N⌬E to NICD (Fig. 2B) .
To further confirm these results we followed the cellular distribution of Notch in confocal immunofluorescence experiments. Cells co-expressing N⌬E and wt PS1, the two FAD-linked L166 mutants, and the artificial PS1 L166S and L166W mutants were permeabilized and co-stained with antibody 9E10 to the myc-tag of N⌬E and with TO-PRO-3 iodide to visualize cell nuclei. Consistent with the results described above, cells expressing wt PS1 or the artificial PS1 L166S mutant showed a prominent nuclear Notch staining, suggesting efficient generation and nuclear translocation of NICD (Fig. 3) . In contrast, cells expressing the PS1 L166P or L166R FAD mutants or the artificial L166W mutant showed much weaker staining of nuclear Notch, confirming the impaired generation and consequently reduced nuclear translocation of NICD (Fig. 3) . Concomitant with reduced staining of nuclear Notch, increased staining of Notch on the cell surface was observed, indicating an inefficient conversion of cell-surface-located N⌬E to NICD. In agreement with previous results (30), cell-surface staining of Notch, representing accumulated uncleaved N⌬E precursor, was observed in cells expressing the PS1 D385A mutant (Fig. 3) . In these cells, very little if any staining of nuclear Notch was observed (Fig. 3) , consistent with an almost complete inhibition of NICD formation (see Fig. 2 ).
PS1 L166 Mutants Differentially Affect AICD Generation. Because some L166 mutants, in particular the FAD-associated L166P mutant, drastically impaired NICD generation, we next investi- gated whether the S3-like ␥-secretase cleavage of APP that generates AICD would also be affected by these mutants. K293͞sw cells stably transfected with either wt PS1, the PS1 L166 mutants, or PS1 D385A were analyzed for AICD generation in in vitro assays that allow the production of robust amounts of AICD (16, 18, 39) . We first analyzed AICD generation from cells expressing wt PS1. In agreement with previous findings, in vitro-generated AICD comigrated with a recombinant AICD variant starting at amino acid 50 of the A␤ domain (AICD 50 ) but not with a recombinant AICD variant starting at amino acid 43 (AICD 57 ) (Fig. 4A) . Thus, these data confirm the efficient production of AICD that is generated by ␥-secretase cleavage predominantly at position 49 of the A␤ domain. We next investigated whether the L166P mutant and the other L166 mutants affect AICD generation. As shown in Fig. 4B , all cell lines contained similar amounts of full-length APP and APP C-terminal fragments, CTF␤ and CTF␣, the substrates of ␥-secretase, with the exception of the PS1 D385A mutant, which caused an expected strong accumulation of CTF␤ and CTF␣ (6) . AICD production was strongly reduced in cells expressing the L166P mutant. Interestingly, the L166W mutant also impaired AICD production consistent with its significant effect on S3 cleavage of Notch (compare Fig. 4 B and C with Fig. 2) , whereas the other mutants displayed differential effects on AICD generation (Fig. 4B) . Consistent with previous results (18, 20, 21) , expression of the biologically inactive PS1 D385A mutant led to an almost complete block of AICD generation. To compare the effects of the L166 mutants on AICD production, we quantified AICD production relative to the amounts of CTF␣, the predominant AICD precursor species in the K293͞sw cells investigated (Fig. 4B) . Quantitation of the AICD͞CTF␣ ratios confirmed the differential effects of the L166 mutants on AICD production (Fig. 4C) . Interestingly, comparison of the effects of the L166 mutants on NICD (Fig. 2B) and AICD production (Fig.  4C) indicated that Notch S3 and APP S3-like ␥-secretase cleavage were affected by the L166 mutants in a similar manner. Indeed, statistical analysis (Spearman rank test) revealed that the effects of the L166 mutants on NICD and AICD production correlated (P Ͻ 0.02).
Discussion
To date, eleven mutations associated with FAD have been reported to be located in TM3 of PS1 (http:͞͞molgen-www.uia.ac.be͞ADMutations͞). Among these mutations, the PS1 L166P mutation is of particular interest because it is associated with disease onset in adolescence. Moreover, the L166P mutation causes an exceptional increase in the A␤ 42 ͞ A␤ total ratio, similar to the FAD-associated PS1 G384A mutation (11, 36) . This extreme increase of A␤ 42 may be due to disruption of TM3 by the helix-breaking proline. Additional mutational analysis of leucine 166 revealed that all L166 mutations investigated cause increased A␤ 42 levels, suggesting that leucine 166 is critically required for the specificity of ␥-secretase cleavage. However, none of the L166 mutations investigated here inhibited ␥-secretase activity. This is different from a recent mutational analysis of glycine 384 that is directly adjacent to the C-terminal active site aspartate of PS1 (11) . Whereas the FAD-associated G384A mutation has been shown to dramatically increase A␤ 42 levels similar to the L166P mutation described here, other (artificial) mutants at position G384 lead to reduced function in APP endoproteolysis in a dominant-negative manner (11) . Thus, unlike ''active site'' mutations that inhibit ␥-secretase activity, the L166 mutants rather influence the preference of ␥-secretase for A␤ 42 versus A␤ 40 cleavage.
It is currently not clear whether pathogenic production of A␤ 42 by PS FAD mutants causes defects in Notch signaling. Studies with PS1 Ϫ/Ϫ cells showed that several FAD-associated PS1 mutations impair Notch signaling (22) . These observations are supported by the finding that FAD mutants show reduced rescuing activity of the egg-laying defect of a mutant C. elegans sel-12 PS homologue (23, 24) . However, these findings may be in conflict with the observation that a FAD-associated mutant PS1 rescues the phenotype of PS1 Ϫ/Ϫ mice (25, 26) . As shown in our study, the mutations at residue 166 affect pathological A␤ 42 production and NICD generation in a differential manner. Increased levels of A␤ 42 did not correlate with decreased NICD production and vice versa (Spearman rank test). For example, the FAD-associated L166P and L166R mutants and the artificial mutant L166W differed drastically in pathological A␤ 42 production but impaired NICD generation in a comparable manner (compare Table 1 and Fig. 2) . Conversely, despite differential increases in pathological A␤ 42 levels, the artificial mutations L166E, L166A, L166S, and L166C allowed NICD generation at moderately reduced or wt levels (compare Table 1 and Fig. 2) . Taken together, these data demonstrate that pathologically elevated levels of A␤ 42 may not necessarily be associated with impaired Notch cleavage and suggest that ␥-secretase cleavage and S3 cleavage can be differentially affected by FAD mutations. Thus, it appears that FAD mutations can have dual effects on PS function. They may cause a toxic gain of misfunction, which is associated with (Bottom) Membranes from K293͞sw cells expressing wt PS1, the PS1 L166 mutants or PS1 D385A were analyzed for the production of AICD as in A. Note the different levels of AICD that are produced in the various cell lines expressing the L166 mutants as compared with cell lines expressing wt PS1 or PS1 D385A. (C) AICD͞CTF␣ ratios were quantified by densitometric scanning and expressed relative to the AICD͞CTF␣ ratio generated in cells expressing wt PS1 that was set 100%. Bars represent the mean Ϯ SE of five independent experiments. The asterisks indicate the significance (two-tailed Student's t test) relative to wt PS1 ( * , P Ͻ 0.01; ** , P Ͻ 0.001).
increased production of the highly amyloidogenic A␤ 42 , but they can also cause a (partial) loss of function in Notch signaling. In that regard, the L166 mutations analyzed here behaved similar as some of the mutations of leucine 286 of PS1 (40) . However, whereas the naturally occurring FAD mutation L286V did not interfere with Notch endoproteolysis, charged amino acid substitutions strongly inhibited NICD generation (40) .
Mutations at position L166 can also affect the PS-dependent, S3-like ␥-secretase cleavage at position 49 of the A␤ domain that results in liberation of AICD from the membrane. This cleavage occurs at a site almost identical to the S3 cleavage site of Notch (18) (19) (20) (21) . A strong reduction of AICD generation was observed with the L166P mutant, demonstrating that FAD-associated PS mutants cannot only affect the generation of NICD, but also that of AICD. Interestingly, AICD production and pathogenic production of A␤ 42 was affected in an individual and differential manner. For example, although the L166P and L166W mutants inhibited AICD generation similarly, they affected A␤ 42 production differentially (compare Table 1 with Fig. 4 B and C) . This finding is further supported by the L166A mutant that did not inhibit AICD generation, despite the production of high A␤ 42 levels. Indeed, statistical analysis revealed that inhibition of AICD generation is not associated with the production of high A␤ 42 levels (Spearman rank test). Further analysis revealed that all L166 mutants affected AICD and NICD production in a similar manner. For example, the mutants that had the strongest inhibitory effect on NICD generation (PS1 L166P and L166W) also had the strongest effect on AICD generation. This finding suggests that S3 protease and S3-like ␥-secretase cleavages are mediated by identical PS-dependent proteolytic activities.
The finding that ␥-secretase cleavage at position 40͞42 and the S3-like ␥-secretase at position 49 of the A␤ domain are differentially affected by PS1 L166 mutants suggests that these cleavages occur either independently from each other in a single pathway or that they occur in two different independent pathways. Thus, although AICD may be principally derived from both APP CTFs, CTF␤, and CTF␣, by the S3-like ␥-secretase cleavage, we cannot exclude the possibility that CTF␤ is the substrate of ␥-secretase-mediated 40͞42 cleavage, whereas AICD is predominantly derived from S3-like ␥-secretase cleavage of CTF␣. At present it is impossible to distinguish between these two possibilities. However, as neither p3 nor A␤ species could be detected (41) , it appears that the S3-like ␥-secretase cleavage of CTF␤ and CTF␣ at position 49 of the A␤ domain cannot occur without initial or simultaneous ␥-secretase cleavage at position 40͞42. This finding suggests that the substrates for AICD generation are cleaved in a single pathway that mediates both cleavages, the ␥-secretase cleavage after position 40͞42 of the A␤ domain and the S3-like ␥-secretase cleavage. This is in agreement with the strict PS-dependence of both cleavages (12, 18, 20, 21) and supports the hypothesis that PSs contribute the catalytic site of ␥-secretase and S3-like ␥-secretase, as well as of S3 protease.
